Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda. - Test2 - elhamkhani - TriplyDB

Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda.

Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda.

http://www.wikidata.org/entity/Q33251914

about

The clinical efficacy of artemether/lumefantrine (Coartem)Antimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR Network Monitoring of efficacy and safety of artemisinin-based anti-malarials for treatment of uncomplicated malaria: a review of evidence of implementation of anti-malarial therapeutic efficacy trials in Tanzania Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda Uncertain outcomes: adjusting for misclassification in antimalarial efficacy studies Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria An economic evaluation of home management of malaria in Uganda: an interactive Markov model Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine Malaria in Uganda: challenges to control on the long road to elimination: I. Epidemiology and current control efforts.Combining individual patient data and aggregate data in mixed treatment comparison meta-analysis: Individual patient data may be beneficial if only for a subset of trials.The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda.Malaria: uncomplicated, caused by Plasmodium falciparum.Update on the efficacy, effectiveness and safety of artemether-lumefantrine combination therapy for treatment of uncomplicated malaria.Incidence of malaria and efficacy of combination antimalarial therapies over 4 years in an urban cohort of Ugandan children.In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda.Outcome of artemether-lumefantrine treatment for uncomplicated malaria in HIV-infected adult patients on anti-retroviral therapy.Plasmodium falciparum dihydrofolate reductase and dihyropteroate synthase mutations and the use of trimethoprim-sulfamethoxazole prophylaxis among persons infected with human immunodeficiency virus Protective efficacy of malaria case management and intermittent preventive treatment for preventing malaria mortality in children: a systematic review for the Lives Saved Tool Evaluation of recurrent parasitemia after artemether-lumefantrine treatment for uncomplicated malaria in children in western Kenya.Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination Malaria: an update on current chemotherapy.Efficacy of quinine, artemether-lumefantrine and dihydroartemisinin-piperaquine as rescue treatment for uncomplicated malaria in Ugandan children.Detection of persistent Plasmodium spp. infections in Ugandan children after artemether-lumefantrine treatment.Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study Comparative safety of artemether-lumefantrine and other artemisinin-based combinations in children: a systematic review Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children.Cardiac Conduction Safety during Coadministration of Artemether-Lumefantrine and Lopinavir/Ritonavir in HIV-Infected Ugandan Adults.Artemether-Lumefantrine Combination Therapy for Treatment of Uncomplicated Malaria: The Potential for Complex Interactions with Antiretroviral Drugs in HIV-Infected Individuals.Assessment of therapeutic efficacy and safety of artemether-lumefantrine (Coartem®) in the treatment of uncomplicated Plasmodium falciparum malaria patients in Bahir Dar district, Northwest Ethiopia: an observational cohort study.Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda Efficacy and Safety of Artesunate-Amodiaquine versus Artemether-Lumefantrine in the Treatment of Uncomplicated Plasmodium falciparum Malaria in Sentinel Sites across Côte d'Ivoire.Repeated artemisinin-based combination therapies in a malaria hyperendemic area of Mali: efficacy, safety, and public health impact Financial implications of refugee malaria: the impact of pre-departure presumptive treatment with anti-malarial drugs Clinical tolerability of artesunate-amodiaquine versus comparator treatments for uncomplicated falciparum malaria: an individual-patient analysis of eight randomized controlled trials in sub-Saharan Africa.Artesunate Plus Amodiaquine (AS+AQ) Versus Artemether -Lumefantrine (AL) for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Sub-Saharan Africa-A Meta-Analysis Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children.Monitoring antimalarial safety and tolerability in clinical trials: a case study from Uganda

P2860

Q21034141-325708B8-BC73-4DAC-A989-726863FF83FE Q26799713-D43A2009-F04B-4E90-8EBC-7A1C03544082 Q26820807-279E42EA-0E23-4AF2-ACC2-7ABA4526EB89 Q28125904-F4B6EDA7-722A-4D04-ACCD-D6C11190B0E1 Q28391984-878AC46F-66F6-475C-B7A2-2027CE0E987F Q28469217-9C44F39F-DA64-410B-AB85-63801F5CC6F2 Q28473004-612F2783-5F8A-4039-84B2-3EDAA2653657 Q28475337-2E0DC3AF-5CA3-489D-8829-8CE3D456274A Q28542034-5D4BDB97-2739-46CA-B689-3F4181883537 Q30226671-DDAB8C89-8FDB-46F1-A9FF-C25EB74EDA24 Q30567158-A1C4EA75-39D4-44E0-BD61-C86F8E3E2A9C Q30936416-0670505B-A7C5-41EA-8849-28F38456A267 Q33342827-6BA0F1C0-20C1-4762-AEC6-10BEC6119900 Q33446846-788EAF32-7FEA-4244-8B34-EDAAAB861E23 Q33635019-EFB94105-630A-45E0-8B34-E9817893ABA7 Q33650896-9B9D043D-6A37-4426-99A2-C31E964FBFCD Q33676088-666D0101-7293-4894-9FA1-B34489F82BFE Q33733033-FD1B45DE-2DAA-4C5D-955E-D438F5D72498 Q33817605-DBDBE355-4A19-419B-8255-C7F1D06D2F68 Q33875677-4A44830D-783F-46A3-B3A6-CB1AC868F65E Q34087271-01BAFA83-EF3B-4E3D-9B43-93CCF613CE89 Q34177472-84314EC5-6546-4A47-8020-6647E1EFA25B Q34433106-F3E8E3A0-62C8-402C-BFC3-E1A1219750A2 Q34562333-1AC4CF45-4C43-42B5-8A7E-40E3358256D9 Q34629332-05DFF3C2-5523-4F18-9278-BF52157E1E16 Q34648820-CFCD3A74-7634-44C1-B6A7-94D9BDCE791A Q34728230-7FFD0834-EF76-4E0E-B6E7-99C7D94D9F0D Q35029488-58B84B54-A354-4A97-B664-62DAA7376E42 Q35607844-EA7ED74C-BA33-4991-B453-DCBCC38F02B7 Q35692134-DAF8DF7A-E351-43F6-989F-6224CAAA1405 Q35692270-F01D08A4-7FD6-4EAA-B089-A1706475638D Q35731736-A3C69491-C7D9-4273-B165-ECE222AEC47F Q35912645-4EF4C0AA-E186-4E09-B607-E449696FD628 Q35996318-19AD0561-D780-474B-851B-A94296A396F9 Q36080127-70CF392F-FCB4-42D3-93CE-5990730CC78C Q36145642-4EF6D6F3-CF56-4147-A8A1-EE273F365EA7 Q36309115-319E69FA-53A8-4150-A9D6-3D4F9CCC8BDB Q36398146-53FAD2C0-A0F4-4B25-8855-6ABA50C86727 Q36739784-967AEB00-A6A2-4ED4-A963-D0689E2E05EF Q36766577-D4FD58D9-FB12-4D34-8CD0-47ED4468F039

P2860

Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda.

http://www.wikidata.org/entity/Q33251914

description

2006 nî lūn-bûn

@nan

2006 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda.

@ast

Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda.

@en

type

label

Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda.

@ast

Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda.

@en

prefLabel

Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda.

@ast

Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda.

@en

P1433

Q33251914-72297307-A051-4441-B381-34C1783A2635

P1476

Q33251914-FC9672E5-BEBA-4CC0-B920-AC86CB041FF1

P2093

Q33251914-19D66290-B161-4038-9BBC-AB74E37FF007

Q33251914-20084861-E458-4106-8CEF-4B5762A13FE2

Q33251914-39E90352-D0DC-471D-ACE9-7E6AE6B22B68

Q33251914-571EC424-CEF6-4E51-96FA-C2B28806DD4B

Q33251914-5C5677EB-68CD-43FF-8886-72B5D8D11235

Q33251914-6F632B24-F73D-4DAA-A34C-41404F7CA40F

P2860

Q33251914-061D40AF-E35E-4F62-92D0-4A7E462CAFE4

Q33251914-0C47CB74-2EC5-41F5-B54F-3463CBF1DD9F

Q33251914-0F4A573F-3967-4BF8-85C8-B42B5893C4D3

Q33251914-1C9FFCFF-A9F2-4FB9-A997-83ED5CEEB410

Q33251914-26C500DA-3AF1-4E92-8689-1E14996320D6

Q33251914-34F99E5C-E262-4E37-A800-161560D7E909

Q33251914-3530E2E0-BAA2-48BB-A358-45534AFD00F6

Q33251914-402E4ED5-0B20-41B5-BABB-F164EBF9B41A

Q33251914-43F6F505-7FE4-4AB5-B61A-1A6E86EF2E73

Q33251914-4A6C7035-D7DC-417F-B54B-FE8699600A3A

P304

Q33251914-FB570AC6-FB18-41B4-B7B8-117F037855BE

P31

Q33251914-E2965253-2641-4CF4-ADE3-A4E577AF8005

P356

Q33251914-F969383A-DF38-4A4C-9908-AE70E9AC02E0

P433

Q33251914-982E3F78-306F-498C-84A0-E204CB19140F

P478

Q33251914-64B23095-EEC7-4605-8E25-7FC39FB0594F

P50

Q33251914-0D630A9F-E378-4150-A012-55C659B31C22

Q33251914-2EE7AB3B-05FA-44A4-8F71-27ACCF391B00

Q33251914-4835AFF4-42BF-4C2D-AED3-9306BF457906

Q33251914-5E73C16E-1145-46F2-8CAA-7776E914E82C

Q33251914-A7C9321C-404C-4E5E-9640-9804696D1632

P577

Q33251914-CCC47513-0B85-4E5D-8E8D-FBDF4FEA5078

P5875

Q33251914-F5CAE96C-D39F-4426-BED3-04575E56BD9C

P698

Q33251914-F66B0A96-C192-4118-9D19-056790511725

P921

Q33251914-3F3DD8E0-4744-4084-99FA-0BC2661D678F

Q33251914-9BC42371-4129-4FC4-83C3-7D807A6038A0

Q33251914-9EAF25DC-A204-44B6-B314-8F4CC5C0A7DA

P932

Q33251914-51DFC60D-832B-4C8D-B005-3002A2B622AF

P356

JOURNAL.PCTR.0010007

P1433

PLOS Clinical Trials

P1476

Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda.

@en

P2093

Adoke Yeka

http://www.w3.org/2001/XMLSchema#string

Ambrose Talisuna

http://www.w3.org/2001/XMLSchema#string

Hasifa Bukirwa

http://www.w3.org/2001/XMLSchema#string

John Bosco Rwakimari

http://www.w3.org/2001/XMLSchema#string

Kristin Banek

http://www.w3.org/2001/XMLSchema#string

Nathan Bakyaita

http://www.w3.org/2001/XMLSchema#string

P2860

Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria

Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether

Intermittent presumptive treatment for malaria

Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa

Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda

Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria.

Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial.

Increasing antimalarial drug resistance in Uganda and revision of the national drug policy.

Trends in antimalarial drug deployment in sub-Saharan Africa.

Artemether-lumefantrine for uncomplicated malaria: a systematic review.

P304

e7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PCTR.0010007

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Fred Wabwire-Mangen

Philip J Rosenthal

Sarah G. Staedke

P577

2006-05-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6915750

http://www.w3.org/2001/XMLSchema#string

P698

16871329

http://www.w3.org/2001/XMLSchema#string

P921

P932

1488893

http://www.w3.org/2001/XMLSchema#string